DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Flumexadol
Flumexadol
)&F1y3x PHARMACEUTICAL APPENDIX to THE
(12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Marrakesh Agreement Establishing the World Trade Organization
(12) Patent Application Publication (10) Pub. No.: US 2011/0159073 A1 De Juan Et Al
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Datasheet Inhibitors / Agonists / Screening Libraries a DRUG SCREENING EXPERT
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Q09012.Pdf (1.659Mb)
Identificación “In Silico” Y Corroboración “In Vitro” De Nuevos Compuestos Con Actividad Analgésica
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
Bioactive Compound Library Plus (96-Well)
Top View
(12) Patent Application Publication (10) Pub. No.: US 2005/0002865 A1 Klaveness Et Al
(12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Customs Tariff - Schedule Xxi - 1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
Identification of Applicable 6-Digit HS Subheadings for Products Covered by the Proposed Uruguay Round Pharmaceutical Agreement
Schedule Clxxiii - European Union